Andrew R Robbins

CIK 1590157 · President and CEO · last filed 2026-05-21

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$21.76M

Companies

2

Total Filings

30

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
COGT President and CEO 657,503 $33.10 $21.76M $0 9 2026-05-21
Harpoon Therapeutics, Inc. (HARP) Delisted Director 0 $23.01 $0 $0 7 2024-03-11

Recent Filings · Page 2 of 3

30 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-05-14 Harpoon Therapeutics, Inc. (HARP) Delisted Grant (A) $0 EDGAR
2021-05-07 Harpoon Therapeutics, Inc. (HARP) Delisted Grant (A) $0 EDGAR
2021-02-12 COGT Grant (A) $0 EDGAR
2020-12-09 COGT Grant (A) $0 EDGAR
2020-10-27 COGT Grant (A) $0 EDGAR
2020-04-01 Harpoon Therapeutics, Inc. (HARP) Delisted Grant (A) $0 EDGAR
2019-07-30 Disp (D) −201,564 -$3.41M
2019-04-03 Mixed +11,028 -$213.0K
2019-02-08 Mixed −114,626 -$4.09M
2018-12-18 Mixed +15,153 -$190.0K
Showing 1120 of 30
Page 2 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.